Abstract The presentation of two cases of veno-occlusive priapism, in patients of 36 and 58 years, in whom the different medical and surgical techniques employed, failed. [nature.com]

C Discuss the immediate implantation of a penile prosthesis with the patient in cases of priapism presenting > 36 hours after onset, or in cases for which all other interventions have failed. [uroweb.org]

Adherence to the recommendations presented in this document cannot assure a successful treatment outcome. For ease of review, the recommendations are bolded and followed by supporting text. [auanet.org]

Objective: To explore the diagnosis and treatment of veno-occlusive priapism. Methods: The diagnosis and treatment of 17 cases of veno-occlusive priapism were analyzed retrospectively. [pubmed.ncbi.nlm.nih.gov]

It should be considered in the differential diagnosis of those patients with veno-occlusive priapism, in whom treatment fails. [nature.com]

Additional tables detailing side effects were developed for some treatments. These results were then summed to provide crude estimates of treatment effects. [auanet.org]

B Disease Management The treatment is sequential and the physician should move on to the next stage if the treatment fails. Figure 1: Treatment of ischaemic priapism * The dose of phenylephrine should be reduced in children. [uroweb.org]

While the etiology of the recurrent ischemic priapism is often idiopathic, patients with hematologic abnormalities, such as sickle cell disease, are more prone to developing recurrent (stuttering) priapism. [auanet.org]

Delayed high-flow priapism: pathophysiology and management. J Urol 1993; 149: 119–121. [nature.com]

Significant advances in the study of erectile physiology during the 1980s and 1990s have led to a better understanding of the pathophysiology of priapism and its management. [auanet.org]

This pattern of recurrence, known as stuttering priapism, challenges the clinician to develop a management strategy to prevent future episodes of priapism. [auanet.org]

B Use hormonal therapies (mainly gonadotropin-receptor hormone agonists or antagonists) and/or antiandrogens for the prevention of future episodes in patients with frequent relapses. Do not use them before sexual maturation is reached. [uroweb.org]